159 related articles for article (PubMed ID: 17223428)
1. Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure.
Shin J; Lobmeyer MT; Gong Y; Zineh I; Langaee TY; Yarandi H; Schofield RS; Aranda JM; Hill JA; Pauly DF; Johnson JA
Am J Cardiol; 2007 Jan; 99(2):250-5. PubMed ID: 17223428
[TBL] [Abstract][Full Text] [Related]
2. Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.
Sehnert AJ; Daniels SE; Elashoff M; Wingrove JA; Burrow CR; Horne B; Muhlestein JB; Donahue M; Liggett SB; Anderson JL; Kraus WE
J Am Coll Cardiol; 2008 Aug; 52(8):644-51. PubMed ID: 18702968
[TBL] [Abstract][Full Text] [Related]
3. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
Savva J; Maqbool A; White HL; Galloway SL; Yuldasheva NY; Ball SG; West RM; De Boer RA; Van Veldhuisen DJ; Balmforth AJ;
J Card Fail; 2009 Jun; 15(5):435-41. PubMed ID: 19477404
[TBL] [Abstract][Full Text] [Related]
5. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
Dhaliwal AS; Habib G; Deswal A; Verduzco M; Souchek J; Ramasubbu K; Aguilar D; Ma TS; Jneid HM; Bolos M; Bozkurt B
Am J Cardiol; 2009 Jul; 104(2):270-5. PubMed ID: 19576359
[TBL] [Abstract][Full Text] [Related]
6. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
[TBL] [Abstract][Full Text] [Related]
7. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
8. Genetic variation in the renin-angiotensin system modifies the beneficial effects of ACE inhibitors on the risk of diabetes mellitus among hypertensives.
Bozkurt O; Verschuren WM; van Wieren-de Wijer BM; Knol MJ; de Boer A; Grobbee DE; Geerlings MI; Heerdink ER; Klungel OH
J Hum Hypertens; 2008 Nov; 22(11):774-80. PubMed ID: 18563171
[TBL] [Abstract][Full Text] [Related]
9. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation.
Auerbach SR; Manlhiot C; Reddy S; Kinnear C; Richmond ME; Gruber D; McCrindle BW; Deng L; Chen JM; Addonizio LJ; Chung WK; Mital S
J Am Coll Cardiol; 2009 May; 53(20):1909-17. PubMed ID: 19442892
[TBL] [Abstract][Full Text] [Related]
10. Role of beta1- and beta2-adrenoceptor polymorphisms in heart failure: a case-control study.
Covolo L; Gelatti U; Metra M; Nodari S; Piccichè A; Pezzali N; Zani C; Alberti A; Donato F; Nardi G; Dei Cas L
Eur Heart J; 2004 Sep; 25(17):1534-41. PubMed ID: 15342173
[TBL] [Abstract][Full Text] [Related]
11. Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial.
Petersen M; Andersen JT; Jimenez-Solem E; Broedbaek K; Afzal S; Nyegaard M; Børglum AD; Stender S; Torp-Pedersen C; Køber L; Poulsen HE
Pharmacogenet Genomics; 2012 Oct; 22(10):709-15. PubMed ID: 22760495
[TBL] [Abstract][Full Text] [Related]
12. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
[TBL] [Abstract][Full Text] [Related]
13. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
14. Insertion/deletion polymorphism in alpha2-adrenergic receptor gene is a genetic risk factor for sudden cardiac death.
Laukkanen JA; Mäkikallio TH; Kauhanen J; Kurl S
Am Heart J; 2009 Oct; 158(4):615-21. PubMed ID: 19781422
[TBL] [Abstract][Full Text] [Related]
15. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of beta-blocker use at the time of hospital discharge as a heart failure performance measure: results from OPTIMIZE-HF.
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
J Card Fail; 2007 Nov; 13(9):722-31. PubMed ID: 17996820
[TBL] [Abstract][Full Text] [Related]
17. Angiotensinogen and ACE gene polymorphisms and risk of atrial fibrillation in the general population.
Ravn LS; Benn M; Nordestgaard BG; Sethi AA; Agerholm-Larsen B; Jensen GB; Tybjaerg-Hansen A
Pharmacogenet Genomics; 2008 Jun; 18(6):525-33. PubMed ID: 18496132
[TBL] [Abstract][Full Text] [Related]
18. Renin-angiotensin system polymorphisms and the association between use of angiotensin II receptor blockers or angiotensin-converting enzyme inhibitors and the risk of diabetes.
Bozkurt O; de Boer A; Grobbee DE; Kroon AA; Schiffers P; de Leeuw P; Klungel OH
J Renin Angiotensin Aldosterone Syst; 2009 Jun; 10(2):101-8. PubMed ID: 19502258
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation associated with ischemic heart failure: a HuGE review and meta-analysis.
Kitsios G; Zintzaras E
Am J Epidemiol; 2007 Sep; 166(6):619-33. PubMed ID: 17644825
[TBL] [Abstract][Full Text] [Related]
20. Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype.
Kaye DM; Smirk B; Finch S; Williams C; Esler MD
J Am Coll Cardiol; 2004 Nov; 44(10):2008-15. PubMed ID: 15542284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
